…of the American Association of Clinical Endocrinologists. A quote:
For newly diagnosed patients, the algorithm lays out treatment decisions based on starting A1C levels. Medication management is recommended for all patients in addition to lifestyle modification. Metformin, incretins, DPP4-inhibitors and alpha-glucosidase inhibitors are the drugs of choice, in the order listed, for initial therapy.
Sulfonylureas and thiazoladinediones are not first-line drugs.
A New York Times opinion piece by a doctor injects a note of caution. Were the guidelines unduly influenced by Big Pharma?
…from the American Association of Clinical Endocrinologists. I haven’t digested them yet, but didn’t want you to have to wait for that. Keep in mind they’re written for healthcare providers, so they may be difficult to understand.
Overweight and obesity are addressed without mention of specific diet recommendations.
You’ll find a nice table summarizing diabetes drugs and their effects on weight and various organ systems. It even includes the brand new SGLT2 inhibitor.